Abstract
In this symposium we chose endoscopic sclerosis of esophageal varices as the prototype of emerging technology for which controls are needed. Experts on clinical studies, institutional review boards, the Food and Drug Administration, legal issues, and ethical issues all comment on the problems raised by such 'small-ticket' items that seldom receive much attention from third-party or others concerned with cost control. It is clear that many emerging technologies fall through the regulatory mesh and that no one is in charge of overseeing such technology.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 258-273 |
| Number of pages | 16 |
| Journal | Journal of clinical gastroenterology |
| Volume | 9 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1987 |
ASJC Scopus subject areas
- Gastroenterology